IPCA LABORATORIES Q2 FY27 CONCALL: RAISES FY27 REVENUE GROWTH GUIDANCE TO 14–16%, MAINTAINS 22–23% EBITDA MARGIN; TARGETS ₹325–340 CR INSTITUTIONAL SALES, 15–16% BRANDED GROWTH & ANNUAL MARGIN IMPROVEMENT OF 100–125 BPS